US Broker Ratings

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 106% Upside Potential Amid Healthcare Industry Dynamics

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the healthcare sector, is currently capturing investor attention with a substantial potential upside of over 106%. As the company navigates the..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling an 83.82% Upside Potential

For investors with an eye on innovation within the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) presents an intriguing opportunity. The New York-based company, with a market capitalization of $1 billion,..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 29.78% Upside Potential in the Diagnostics Sector

Veracyte, Inc. (NYSE: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.9 billion, this South San Francisco-based company is..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Strong Revenue Growth Amidst Lack of Analyst Ratings

National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, operates a diversified portfolio of medical care facilities across the United States. This company, with a robust market..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring Value Amidst Challenges with a 4.67% Dividend Yield

DENTSPLY SIRONA Inc. (XRAY), a key player in the healthcare sector, particularly in medical instruments and supplies, is drawing investor attention with its robust 4.67% dividend yield despite facing several..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring the 68% Potential Upside for Investors

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is catching the attention of investors looking for high-growth opportunities within the healthcare sector. As a clinical-stage pharmaceutical company, Centessa is focused on discovering, developing,..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Analyzing a 16.71% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in managing senior living communities across the United States. With a market capitalization of $3.87 billion,..

Organon & Co. (OGN) Stock Analysis: Exploring a Potential 18.3% Upside in Healthcare

Organon & Co. (NYSE: OGN), a noteworthy player in the general drug manufacturing sector, presents an intriguing opportunity for investors interested in the healthcare landscape. With a market capitalization of..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 69.80% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of genetic innovation with its cutting-edge CRISPR/Cas9 platform, targeting a vast array of serious human diseases. As individual investors evaluate their..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook Reveals a 25% Upside Potential in a Rising Biotech Star

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its promising developments in the biotechnology sector, particularly in the realm of neurological treatments. With a market capitalization of..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 13.75% Potential Upside in Healthcare’s Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (CNMD) an intriguing proposition. With a market capitalization of $1.29 billion, this American medical device company operates within the..

Certara, Inc. (CERT) Investor Outlook: Exploring a Promising 72.59% Potential Upside

Certara, Inc. (NASDAQ: CERT), a company positioned within the healthcare sector, specifically in health information services, is capturing investor interest with its compelling growth narrative and significant potential upside. Headquartered..

Tarsus Pharmaceuticals, Inc. (TARS)

⚠️ No article content returned.

..

Investor Outlook: Ascentage Pharma Group Internat (AAPG) Poised for 93.62% Upside with Strong Analyst Support

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is capturing the attention of investors with its innovative pipeline focused on cancer therapies, chronic hepatitis B,..

Warby Parker Inc. (WRBY) Stock Analysis: 12.88% Potential Upside Beckons Investors

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, continues to attract investor interest with its innovative business model and impressive growth trajectory. As a company operating..

LivaNova PLC (LIVN) Stock Analysis: Unveiling a 11% Potential Upside in the Medical Devices Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical devices industry, is capturing investor attention with its intriguing mix of growth potential and compelling market position. Headquartered in London,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Potential 32% Upside Captures Investor Attention

As investors continuously seek promising opportunities in the healthcare sector, LifeStance Health Group, Inc. (NASDAQ: LFST) stands out with a compelling potential upside of 32.16%, according to recent analyst ratings...

ACADIA Pharmaceuticals Inc. (ACAD): Investor Outlook Reveals 34% Upside Potential Amid Robust CNS Pipeline

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company specializing in central nervous system (CNS) disorders, is gaining attention from investors looking for promising growth potential in the healthcare sector. With..

Galapagos NV (GLPG) Stock Analysis: Navigating a Volatile Biotech Landscape with a -16.40% Investor Outlook

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, has carved out a niche in the healthcare sector with its focus on innovative treatments in oncology and immunology. Despite its promising..

GeneDx Holdings Corp. (WGS): Investor Outlook Highlights 86.32% Potential Upside Amid Robust Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a key player in the diagnostics and research sector, has captured investor attention with its promising growth potential and a significant upside opportunity. As a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds